Betaferon sales likely to boost Schering's growth

Article Abstract:

Analysts said that Schering AG should see a growth in sales of its core Betaferon product in 1999. This should help the company's financial performance for the year. Betaferon is a drug treatment for multiple sclerosis. Schering's sales in 1998 struggled because of disadvantageous currency rates. The company said that its yearly group sales increased 2.9% to 6.4 billion marks ($3.68 billion).

Comment:

Analysts say co's 1999 performance should be helped by expected Betaferon sales

Germany, Forecasts, trends, outlooks, Abstract, Schering AG

---

Novo Nordisk's net beats expectations with a 54% jump

Article Abstract:

Novo Nordisk AS posted a higher-than-expected increase of 54% in its net profits for the 2000 year. The company posted 3.09 billion Danish kroner (414 million euros) in net profits for the year.

Novo Nordisk A/S

---

Danske Bank's net profit falls

Article Abstract:

Danske Bank A.S posted a drop of 5.4% in its net profits for the 2002 year. The bank posted 8.24 billion Danish kroner (1.11 billion euros) in net profits for the year.

Banking industry, Company sales and earnings, Company earnings/profit, Danske Bank A/S

Similar abstracts:

• Abstracts: Merging German banks post promising results. Dresdner Bank's net forecast to be solid. Credit Suisse gets ready for expansion in Germany
• Abstracts: Transition from cash dispensers to traders. Raiffeisenbank raises profit by a half. Konsolidacni Banka
• Abstracts: Havas aims to buy Anaya as part of Spanish growth. Argentaria to sell 40% of BCL unit to Dexia. European Companies Forge World's Largest Steel producer
• Abstracts: Energy Crisis Tests Management Style Of New President. A Danish Island touts clean energy, but reality sets in
• Abstracts: Boardroom struggle grows at Malaysia's Landmarks. Tan diversifies by acquiring Parkway stake. Gadek draws creditor ire

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.